APP下载

大黄承气汤联合乌司他丁对重症急性胰腺炎患者肠黏膜功能及免疫功能的影响

2018-10-21李辉戚正涛宋文集陈凯达蔡建彬

世界中医药 2018年6期

李辉 戚正涛 宋文集 陈凯达 蔡建彬

摘要 目的:探讨大黄承气汤联合乌司他丁对重症急性胰腺炎(SAP)的治疗效果及对患者肠道黏膜功能、免疫功能的影响。方法:选取2014年1月至2017年6月广州中医药大学第三附属医院收治的SAP患者128例,按照乱数表法分为观察组与对照组,每组64例。2组均给予SAP常规治疗及乌司他丁治疗,观察组同时给予大黄承气汤胃管注入治疗,对照组则给予生理盐水胃管注入治疗,疗程均为2周。观察2组治疗后急性生理与慢性健康评分(APACHE-Ⅱ)、全身炎性反应综合征(SIRS)改善时间、肠功能恢复时间、住院时间、多器官功能衰竭(MODS)发生率、死亡率。比较2组治疗前、后腹内压、血浆二胺氧化酶(DAO)、血浆D-乳酸、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)以及免疫球蛋白IgM、IgA、IgG水平。结果:治疗后观察组APACHE-Ⅱ、SIRS改善时间、肠功能恢复时间及住院时间均明显低于对照组,MODS发生率和死亡率明显低于对照组(P<0.05)。治療后,观察组腹内压、DAO及血浆D-乳酸明显低于对照组(P<0.05)。治疗后2组患者血清IL-6、IL-8及TNF-α水平均明显降低,且观察组明显低于对照组(P<0.05)。治疗后观察组患者血清IgM、IgA、IgG水平均明显升高,对照组IgM、IgA、IgG水平明显降低(P<0.05),观察组患者血清IgM、IgA、IgG水平明显高于对照组(P<0.05)。结论:大黄承气汤联合乌司他丁治疗SAP时临床疗效较好,可有效降低炎性反应因子水平,增强免疫功能,值得临床推广应用。

关键词 重症急性胰腺炎;大黄承气汤;乌司他丁;炎性反应因子;肠黏膜功能

AbstractObjective:Toinvestigatethetherapeuticeffectofrhubarbchengqidecoctioncombinewithulinastatinonsevereacutepancreatitis(SAP)anditsinfluenceonintestinalmucosalfunctionandimmunefunctionofpatients.Methods:Atotalof128patientswithSAPwhoweretreatedinourhospitalfromJanuary2014toJune2017wereselected,theyweredividedintoobservationgroup(n=64)andcontrolgroup(n=64)accordingtorandomnumbertable.ThetwogroupsweregivenconventionaltreatmentofSAPandulinastatintreatment,theobservationgroupwasgivenrhubarbchengqidecoctiongastrictubeinjection,thecontrolgroupwasgivenphysiologicalsalinegastrictubeinjectiontreatment,thecourseoftreatmentwas2weeks.Theacutephysiologyandchronichealthevaluation(APACHE-II),improvementtimeofsystemicinflammatoryresponsesyndrome(SIRS),recoverytimeofintestinalfunction,Lengthofhospitalstay,incidenceofmultipleorganfailure(MODS)andmortalitywereobserved.Theintra-abdominalpressure,plasmatwoamineoxidase(DAO),plasmaD-lacticacid,interleukin-6(IL-6),interleukin-8(IL-8),tumornecrosisfactor-α(TNF-α),immunoglobulinIgM,IgAandIgGlevelswerecomparedbetweenthetwogroupsbeforeandaftertreatment.Results:TheimprovementtimeofAPACHE-II,SIRS,therecoverytimeofintestinalfunctionandthelengthofstayintheobservationgroupaftertreatmentweresignificantlylowerthanthoseinthecontrolgroup,theincidenceofmortalityandMODSweresignificantlylowerthanthoseofthecontrolgroup(P<0.05).Aftertreatment,theintra-abdominalpressure,DAOandplasmalacticacidintheobservationgroupweresignificantlylowerthanthoseinthecontrolgroup(P<0.05).Aftertreatment,theserumlevelsofIL-6,IL-8andTNF-αinthetwogroupsweresignificantlydecreased,andtheobservationgroupwassignificantlylowerthanthatofthecontrolgroup(P<0.05).Aftertreatment,theserumlevelsofIgM,IgAandIgGintheobservationgroupweresignificantlyincreased,andthelevelsofIgM,IgAandIgGinthecontrolgroupweresignificantlydecreased(P<0.05).TheserumlevelsofIgM,IgAandIgGintheobservationgroupweresignificantlyhigherthanthoseinthecontrolgroup(P<0.05).Conclusion:RhubarbchengqidecoctioncombinewithulinastatininthetreatmentofSAPhavegoodclinicalcurativeeffect,caneffectivelyreducethelevelofinflammatoryfactors,andenhancingimmunefunction,whichisworthyofclinicalapplication.

KeyWordsSevereacutepancreatitis;Rhubarbchengqidecoction;Ulinastatin;Inflammatoryfactors;Intestinalmucosalfunction

中图分类号:R256.33文献标识码:Adoi:10.3969/j.issn.1673-7202.2018.06.025

重症急性胰腺炎(SevereAcutePancreatitis,SAP)是临床上最为凶险的急腹症,具有发病急骤、病情变化迅速、并发症多等特点,病死率高达30%以上[1]。有报道显示,SAP在早期可激活体内多种炎性反应因子,并能引发多器官功能障碍(MultipleOrganDysfunctionSyndrome,MODS)或全身炎性反应综合征(SystemicInflammatoryResponseSyndrome,SIRS),最终导致患者死亡[2]。相关研究表明,胃肠道黏膜功能损伤和免疫功能激活在SAP发生发展中起到重要作用[3]。因此如何降低胃肠道黏膜功能损伤,稳定机体免疫功能是提高SAP救治率的关键。……

登录APP查看全文